David S. DeLuca

14.7k total citations · 1 hit paper
65 papers, 2.0k citations indexed

About

David S. DeLuca is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David S. DeLuca has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David S. DeLuca's work include T-cell and B-cell Immunology (13 papers), vaccines and immunoinformatics approaches (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). David S. DeLuca is often cited by papers focused on T-cell and B-cell Immunology (13 papers), vaccines and immunoinformatics approaches (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). David S. DeLuca collaborates with scholars based in Germany, United States and Spain. David S. DeLuca's co-authors include Andrey Sivachenko, Joshua Z. Levin, Timothy R. Fennell, Gad Getz, Chris Williams, Michael Reich, Wendy Winckler, Marc-Danie Nazaire, Rainer Blasczyk and Nathalie Pochet and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Bioinformatics.

In The Last Decade

David S. DeLuca

64 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA-SeQC: RNA-seq metrics for quality control and process optimization

2012 501 citations David S. DeLuca, Joshua Z. Levin et al. profile →

Peers

Countries citing papers authored by David S. DeLuca

Since Specialization

Citations

This map shows the geographic impact of David S. DeLuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. DeLuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. DeLuca more than expected).

Fields of papers citing papers by David S. DeLuca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. DeLuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. DeLuca. The network helps show where David S. DeLuca may publish in the future.

Co-authorship network of co-authors of David S. DeLuca

This figure shows the co-authorship network connecting the top 25 collaborators of David S. DeLuca. A scholar is included among the top collaborators of David S. DeLuca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. DeLuca. David S. DeLuca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation 2024 ·Clinical Biochemistry ·Urszula Lechowicz, Beatriz Martı́nez-Delgado, (unknown), Sabine Wrenger, (unknown), (unknown), David S. DeLuca, Tobias Welte, Sabina Janciauskiene, Joanna Chorostowska‐Wynimko	1
2	A variational autoencoder trained with priors from canonical pathways increases the interpretability of transcriptome data 2024 ·PLoS Computational Biology ·(unknown), Bodo Rosenhahn, Thomas Illig, David S. DeLuca	1
3	Trends of extreme hyperbilirubinemia related infant mortality in select European countries (1990–2019) 2024 ·Pediatric Research ·Ramesh Vidavalur, (unknown), Carlo Dani, Sotirios Fouzas, (unknown), Manuel Sánchez Luna, Vinod K. Bhutani, David S. DeLuca	3
4	Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE) 2023 ·Journal of Breath Research ·(unknown), Nicole Maison, Lennart Riemann, (unknown), David S. DeLuca, Sven Schuchardt, (unknown), Markus Weckmann, Anna‐Maria Dittrich, Bianca Schaub, Folke Brinkmann, Gesine Hansen, Matthias Kopp, Erika von Mutius, Klaus F. Rabe, Thomas Bahmer, Jens M. Hohlfeld, Ruth Grychtol, Olaf Holz, (unknown)	1
5	Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), David S. DeLuca, (unknown), (unknown), (unknown), Martin Wetzke, Christian Dopfer, Annette Sauer‐Heilborn, Felix C. Ringshausen, Sibylle Junge, Burkhard Tümmler, Gesine Hansen, Anna‐Maria Dittrich	5
6	Single cell versus single nucleus: transcriptome differences in the murine kidney after ischemia-reperfusion injury 2022 ·American Journal of Physiology-Renal Physiology ·(unknown), (unknown), Oliver Dittrich‐Breiholz, Hermann Haller, (unknown), (unknown), (unknown), Payel Sen, Sibylle von Vietinghoff, David S. DeLuca, Roland Schmitt	12
7	Loss of Serpina1 in Mice Leads to Altered Gene Expression in Inflammatory and Metabolic Pathways 2022 ·International Journal of Molecular Sciences ·(unknown), Beatriz Martı́nez-Delgado, (unknown), Gema Gómez‐Mariano, Sara Pérez-Luz, (unknown), Sabine Wrenger, David S. DeLuca, Ulrich A. Maus, Tobias Welte, Sabina Janciauskiene	10
8	Assessing treatment outcomes in CLAD: The Hannover-extracorporeal photopheresis model 2022 ·The Journal of Heart and Lung Transplantation ·Mark Greer, Bin Liu, Jesper Magnusson, Thomas Fuehner, (unknown), David S. DeLuca, Christine S. Falk, F. Ius, Tobias Welte	9
9	Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene 2022 ·Cancers ·(unknown), Marc A. Schneider, (unknown), Mark Kriegsmann, H. Winter, Beatriz Martı́nez-Delgado, Sarai Varona, Bin Liu, David S. DeLuca, Julia Held, Sabine Wrenger, Thomas Muley, Michael Meister, Tobias Welte, Sabina Janciauskiene	1
10	Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs 2021 ·eLife ·(unknown), Matthias Ballmaier, Sabine Wrenger, (unknown), Matthias Lehmann, Ralf Lichtinghagen, Beatriz Martı́nez-Delgado, Elena Korenbaum, David S. DeLuca, (unknown), Tobias Welte, Malin Fromme, Pavel Strnad, Jan Stolk, Sabina Janciauskiene	4
11	SERPINA1 gene polymorphisms in a population‐based ALSPAC cohort 2019 ·Pediatric Pulmonology ·David S. DeLuca, (unknown), (unknown), Sabine Wrenger, Algirdas Utkus, Algirdas Vaclovas Valiulis, (unknown), John Henderson, Andrew Bush, Tobias Welte, Sabina Janciauskiene, (unknown), (unknown)	8
12	Complications and risk factors in pediatric bronchoscopy in a tertiary pediatric respiratory center 2018 ·Pediatric Pulmonology ·Julia Carlens, Jan Fuge, (unknown), David S. DeLuca, Mareike Price, Gesine Hansen, Nicolaus Schwerk	28
13	SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas 2014 ·Journal of Clinical Investigation ·Hideo Watanabe, Qiuping Ma, Shouyong Peng, Guillaume Adelmant, (unknown), Wenyu Song, Cameron Fox, Joshua M. Francis, Chandra Sekhar Pedamallu, David S. DeLuca, Angela N. Brooks, Su Wang, Jianwen Que, Anil K. Rustgi, Kwok‐Kin Wong, Keith L. Ligon, (unknown), Jarrod A. Marto, Matthew Meyerson, Adam J. Bass	118
14	Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2013 ·Digital Access to Scholarship at Harvard (DASH) (Harvard University) ·Xian Adiconis, Diego Borges-Rivera, Rahul Satija, David S. DeLuca, Michele Busby, Aaron M. Berlin, Andrey Sivachenko, Dawn Thompson, Alec Wysoker, Timothy R. Fennell, Andreas Gnirke, Nathalie Pochet, Aviv Regev, Joshua Z. Levin	332
15	Comparative analysis of RNA sequencing methods for degraded or low-input samples 2013 ·Nature Methods ·Xian Adiconis, Diego Borges-Rivera, Rahul Satija, David S. DeLuca, Michele Busby, Aaron M. Berlin, Andrey Sivachenko, Dawn Thompson, Alec Wysoker, Timothy R. Fennell, Andreas Gnirke, Nathalie Pochet, Aviv Regev, Joshua Z. Levin	18
16	Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients 2012 ·Clinical Cancer Research ·Ann Cai, Derin B. Keskin, David S. DeLuca, Anselmo Alonso, Wandi Zhang, Guang Lan Zhang, (unknown), Valentina Nardi, Richard M. Stone, Donna Neuberg, John Sidney, Vladimir Brusić, Catherine J. Wu	40
17	MULTIPRED2: A computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles 2010 ·Journal of Immunological Methods ·Guang Lan Zhang, David S. DeLuca, Derin B. Keskin, Lou Chitkushev, (unknown), Ole Lund, Ellis L. Reinherz, Vladimir Brusić	50
18	The immunoinformatics of cancer immunotherapy 2007 ·Tissue Antigens ·David S. DeLuca, Rainer Blasczyk	15
19	An amino acid contributing to pockets A, B, and D of the peptide‐binding groove is altered in A0315† 2005 ·Tissue Antigens* ·Péter Horn, David S. DeLuca, Rainer Blasczyk	2
20	HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool 2003 ·Bone Marrow Transplantation ·(unknown), David S. DeLuca, (unknown), Rainer Blasczyk	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact